This research project focuses on patients with arrhythmic mitral valve prolapse. There is a lack of data on prognostics risk markers and the effect of antiarrhythmic therapy in patients with arrhythmic mitral valve prolapse.
Our aim is to improve general knowledge about ventricular arrhythmias in these patients, by better understanding arrhythmia mechanics, triggers and substrates. We also want to explore possible treatment options for decreasing ventricular arrhythmia burden in these patients. By better understanding the characteristics of arrhythmic mitral valve prolapse, we can better target risk stratification to prevent sudden cardiac death and provide better treatment options of these patients. This project is performed in collaboration with our partners at Oslo University Hospital, Simula and Medronic.
